These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1016340)

  • 21. [Drug safety: activities of the manufacturer].
    Krupp P
    Soz Praventivmed; 1980 Mar; 25(1-2):14-7. PubMed ID: 7424173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Something to be done: treating HIV/AIDS. River Path Associates.
    Bloom DE
    Science; 2000 Jun; 288(5474):2171-3. PubMed ID: 10864858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses.
    Bell JS; Whitehead P; Aslani P; McLachlan AJ; Chen TF
    Clin Drug Investig; 2006; 26(7):415-25. PubMed ID: 17163274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indicators of rational drug use and health services in Hadramout, Yemen.
    Bashrahil KA
    East Mediterr Health J; 2010 Feb; 16(2):151-5. PubMed ID: 20799566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-marketing surveillance: drug epidemiology.
    Borden EK
    J Int Med Res; 1981; 9(6):401-7. PubMed ID: 7319130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Provision of medicines in a developing country.
    Yudkin JS
    Lancet; 1978 Apr; 1(8068):810-2. PubMed ID: 85826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of drug information centres for improving patient care in Pakistan and other developing countries.
    Arbab AG
    J Pak Med Assoc; 1977 Mar; 27(3):300-2. PubMed ID: 409864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the market for tuberculosis drugs in industrialized and developing nations.
    Schwalbe NR; Wells WA; Geaneotes AP; Forcellina A; Lee MG; Dicola L; Ignatius HR; Walker CL; Raafat T; Patel N
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1173-81. PubMed ID: 18812048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmaceutical industry as a medicines provider.
    Henry D; Lexchin J
    Lancet; 2002 Nov; 360(9345):1590-5. PubMed ID: 12443614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Information systems for the analysis of drug prescriptions in Spain.
    Ferrando MC
    Ann Ist Super Sanita; 1991; 27(2):213-6. PubMed ID: 1755573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Published pediatric randomized drug trials in developing countries, 1996-2002.
    Nor Aripin KN; Sammons HM; Choonara I
    Paediatr Drugs; 2010 Apr; 12(2):99-103. PubMed ID: 20218746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.
    Angamo MT; Chalmers L; Curtain CM; Bereznicki LR
    Drug Saf; 2016 Sep; 39(9):847-57. PubMed ID: 27449638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provision of medicines in Ecuador.
    Johnston TS
    Lancet; 1980 May; 1(8177):1073-4. PubMed ID: 6103403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004.
    Divac N; Tosevski DL; Babić D; Djurić D; Prostran M; Samardzić R
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):835-8. PubMed ID: 16958148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of pharmaceuticals in the total health care of developing countries.
    Hoekenga MT
    Am J Trop Med Hyg; 1983 May; 32(3):437-46. PubMed ID: 6859394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data sources and methods for ascertaining human exposure to drugs.
    Jones JK; Kennedy DL
    J Toxicol Clin Toxicol; 1983-1984; 21(1-2):237-51. PubMed ID: 6672220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic drug use in Bangladesh: policy versus practice.
    Islam MS
    Indian J Med Ethics; 2008; 5(1):24-5. PubMed ID: 18630250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug utilization studies and people. A Swedish perspective.
    Tomson G
    Ann Ist Super Sanita; 1991; 27(2):239-45. PubMed ID: 1755577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Off-label and unlicensed prescribing for children: have we made any progress?
    Waller DG
    Br J Clin Pharmacol; 2007 Jul; 64(1):1-2. PubMed ID: 17577389
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the adverse drug reaction surveillance system Kadoma City, Zimbabwe 2015.
    Muringazuva C; Chirundu D; Mungati M; Shambira G; Gombe N; Bangure D; Juru T; Tshimanga M
    Pan Afr Med J; 2017; 27():55. PubMed ID: 28819477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.